CPhI Worldwide Celebrates 25 Years with #CPhI25 Success Stories
CPhI Worldwide releases "25 pharma stories made at CPhI" for 25th anniversary.
In celebration of the event’s 25th anniversary, CPhI Worldwide is releasing a series of pharma stories ‘made at CPhI’. The first of the 25 stories was released on Oct. 2, 2014. Each of the 25 stories will follow pharmaceutical industry successes that were direct results of meetings at CPhI. Global Pharamceutical Relief, a global pharmaceutical and medical supply distributer focused on supplying sustainable logistic strategies in information, communication, and transport technologies, shared their story, having met for the first time at CPhI in 2012.
"It all started with an idea on the back of a napkin, but the key suppliers and manufacturers we met at CPhI enabled us to turn this into a reality. Now when there is an emergency and governments and NGOs need a medial treatment supplied, Global Pharmaceutical Relief is able to help, all thanks to the distribution and supplier agreements made at the CPhI Worldwide,” said Matthew Rosen, CEO at Global Pharmaceutical Relief. Their story can be viewed on CPhI’s YouTube channel.
CPhI invites all attendees to tweet their success stories to #CPhI25 and join the #CPhIfamily. All 25 stories will be released after the event in an ebook.
Source: CPhI
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
